$LNSR
LENSAR Inc

2023 Q2 Form 10-Q Financial Statement

#000095017023022253 Filed on May 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $12.01M $8.252M $7.941M
YoY Change 49.44% 3.92% 12.75%
Cost Of Revenue $5.251M $3.932M $4.648M
YoY Change 66.91% -15.4% 47.6%
Gross Profit $6.761M $4.320M $4.692M
YoY Change 38.21% -7.93% 20.49%
Gross Profit Margin 56.29% 52.35% 59.09%
Selling, General & Admin $7.854M $6.755M $6.278M
YoY Change 3.77% 7.6% 4.03%
% of Gross Profit 116.17% 156.37% 133.8%
Research & Development $1.499M $1.650M $4.788M
YoY Change -60.9% -65.54% 74.36%
% of Gross Profit 22.17% 38.19% 102.05%
Depreciation & Amortization $855.0K $578.0K $541.0K
YoY Change -0.12% 6.84% 64.94%
% of Gross Profit 12.65% 13.38% 11.53%
Operating Expenses $9.353M $8.405M $11.38M
YoY Change -17.98% -26.11% 29.54%
Operating Profit -$2.867M -$4.361M -$6.683M
YoY Change -57.83% -34.74% 28.52%
Interest Expense $111.0K $89.00K $9.000K
YoY Change 184.62% 888.89% -55.0%
% of Operating Profit
Other Income/Expense, Net $111.0K $89.00K $9.000K
YoY Change 184.62% 888.89% -50.0%
Pretax Income -$8.753M -$4.272M -$6.674M
YoY Change 29.5% -35.99% 28.84%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$8.753M -$4.272M -$6.674M
YoY Change 29.5% -35.99% 28.79%
Net Earnings / Revenue -72.87% -51.77% -84.04%
Basic Earnings Per Share -$0.81 -$0.40 -$0.67
Diluted Earnings Per Share -$0.81 -$0.40 -$669.6K
COMMON SHARES
Basic Shares Outstanding 11.10M 11.10M 9.967M
Diluted Shares Outstanding 10.82M 10.72M 9.967M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.47M $7.970M $28.98M
YoY Change 1.07% -72.5% -19.2%
Cash & Equivalents $25.47M $7.970M $28.98M
Short-Term Investments
Other Short-Term Assets $903.0K $1.070M $1.508M
YoY Change -26.59% -29.05% -17.14%
Inventory $18.15M $15.67M $4.279M
Prepaid Expenses
Receivables $3.223M $4.660M $3.585M
Other Receivables $595.0K $203.0K $194.0K
Total Short-Term Assets $49.16M $29.98M $38.55M
YoY Change 39.65% -22.24% -27.6%
LONG-TERM ASSETS
Property, Plant & Equipment $605.0K $520.0K $755.0K
YoY Change -11.03% -31.13% 1.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.476M $2.605M $3.082M
YoY Change -16.07% -15.48% -14.91%
Total Long-Term Assets $22.03M $21.99M $21.75M
YoY Change -6.22% 1.09% 7.14%
TOTAL ASSETS
Total Short-Term Assets $49.16M $29.98M $38.55M
Total Long-Term Assets $22.03M $21.99M $21.75M
Total Assets $71.20M $51.96M $60.30M
YoY Change 21.29% -13.83% -18.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.619M $4.923M $2.852M
YoY Change 10.21% 72.62% 67.57%
Accrued Expenses $4.321M $3.493M $3.406M
YoY Change -1.17% 2.55% 23.36%
Deferred Revenue $1.067M $1.032M $989.0K
YoY Change 13.87% 4.35% 2.28%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.56M $9.992M $7.763M
YoY Change -5.93% 28.71% 30.95%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $568.0K $360.0K $52.00K
YoY Change 1435.14% 592.31% -46.39%
Total Long-Term Liabilities $568.0K $360.0K $52.00K
YoY Change 1435.14% 592.31% -46.39%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.56M $9.992M $7.763M
Total Long-Term Liabilities $568.0K $360.0K $52.00K
Total Liabilities $24.76M $12.52M $10.49M
YoY Change 79.44% 19.41% 13.82%
SHAREHOLDERS EQUITY
Retained Earnings -$110.5M -$101.8M -$84.27M
YoY Change 21.43% 20.78% 33.39%
Common Stock $143.2M $141.2M $134.1M
YoY Change 5.37% 5.32% 5.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $32.69M $39.44M $49.81M
YoY Change
Total Liabilities & Shareholders Equity $71.20M $51.96M $60.30M
YoY Change 21.29% -13.83% -18.01%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$8.753M -$4.272M -$6.674M
YoY Change 29.5% -35.99% 28.79%
Depreciation, Depletion And Amortization $855.0K $578.0K $541.0K
YoY Change -0.12% 6.84% 64.94%
Cash From Operating Activities -$2.144M -$6.696M -$2.607M
YoY Change -23.15% 156.85% -43.56%
INVESTING ACTIVITIES
Capital Expenditures $181.0K $8.000K -$46.00K
YoY Change -1910.0% -117.39% -140.35%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$181.0K -$8.000K -$46.00K
YoY Change 1710.0% -82.61% -59.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 19.82M
YoY Change -2106.17%
NET CHANGE
Cash From Operating Activities -2.144M -6.696M -2.607M
Cash From Investing Activities -181.0K -8.000K -46.00K
Cash From Financing Activities 19.82M
Net Change In Cash 17.50M -6.704M -2.653M
YoY Change -561.88% 152.7% -43.95%
FREE CASH FLOW
Cash From Operating Activities -$2.144M -$6.696M -$2.607M
Capital Expenditures $181.0K $8.000K -$46.00K
Free Cash Flow -$2.325M -$6.704M -$2.561M
YoY Change -16.37% 161.77% -45.89%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P9M
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001320350
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-39473
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
LENSAR, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
32-0125724
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2800 Discovery Drive
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Orlando
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32826
CY2023Q1 dei City Area Code
CityAreaCode
888
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
536-7271
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Trading Symbol
TradingSymbol
LNSR
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q4 us-gaap Assets Current
AssetsCurrent
33716000
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11102611
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
1629000
CY2022Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
1399000
CY2023Q1 us-gaap Revenues
Revenues
8252000
CY2022Q1 us-gaap Revenues
Revenues
9340000
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
3932000
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
4648000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6755000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6278000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1650000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4788000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
276000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
309000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4361000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-6683000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
89000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4272000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-6674000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.67
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.67
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10716000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10716000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9967000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9967000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7970000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14674000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
43000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
56000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4660000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6040000
CY2023Q1 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
4000
CY2022Q4 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
4000
CY2023Q1 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
203000
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
200000
CY2023Q1 us-gaap Inventory Net
InventoryNet
15668000
CY2022Q4 us-gaap Inventory Net
InventoryNet
11740000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1474000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1062000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
29975000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
520000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
563000
CY2023Q1 lnsr Equipment Under Lease Net
EquipmentUnderLeaseNet
6248000
CY2022Q4 lnsr Equipment Under Lease Net
EquipmentUnderLeaseNet
6316000
CY2023Q1 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
16000
CY2022Q4 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
9000
CY2023Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
768000
CY2022Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
442000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11845000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
12122000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2605000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2685000
CY2023Q1 us-gaap Assets
Assets
51961000
CY2022Q4 us-gaap Assets
Assets
55844000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
4923000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5422000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3493000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4700000
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1032000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
768000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
544000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
531000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
9992000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11421000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2171000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2272000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
360000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
167000
CY2023Q1 us-gaap Liabilities
Liabilities
12523000
CY2022Q4 us-gaap Liabilities
Liabilities
13860000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11103000
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11103000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11093000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11093000
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
111000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
111000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
141107000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
139381000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-101780000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-97508000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
39438000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
41984000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51961000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
55844000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-4272000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-6674000
CY2023Q1 us-gaap Depreciation
Depreciation
578000
CY2022Q1 us-gaap Depreciation
Depreciation
541000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
276000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
309000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
133000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
130000
CY2023Q1 lnsr Provision For Doubtful Accounts And Notes Receivable
ProvisionForDoubtfulAccountsAndNotesReceivable
-6000
CY2022Q1 lnsr Provision For Doubtful Accounts And Notes Receivable
ProvisionForDoubtfulAccountsAndNotesReceivable
134000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1726000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1607000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1393000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1037000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
427000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-192000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4381000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1116000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-499000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
158000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1197000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1198000
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
20000
CY2022Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-41000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6696000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2607000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
46000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-46000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6704000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2653000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14674000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
31637000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7970000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
28984000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
1000
CY2023Q1 lnsr Transfer From Inventories To Equipment Under Lease Net
TransferFromInventoriesToEquipmentUnderLeaseNet
881000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q1 lnsr Transfer From Inventories To Equipment Under Lease Net
TransferFromInventoriesToEquipmentUnderLeaseNet
1060000
CY2023Q1 lnsr Transfer From Inventories To Property And Equipment Net
TransferFromInventoriesToPropertyAndEquipmentNet
-428000
CY2022Q1 lnsr Transfer From Inventories To Property And Equipment Net
TransferFromInventoriesToPropertyAndEquipmentNet
34000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
41984000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1726000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4272000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
39438000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
54879000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1607000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-6674000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
49812000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-101780000
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounting Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed financial statements and accompanying notes to the condensed financial statements. The accounting estimates that require management’s most significant, difficult and subjective judgments include, but are not limited to, revenue recognition and allowance for expected credit losses, the valuation of notes receivable and inventory, the assessment of recoverability of intangible assets and their estimated useful lives, the valuation and recognition of stock-based compensation, operating lease right-of-use assets and liabilities, and the recognition and measurement of current and deferred income tax assets and liabilities. Management evaluates its estimates on an ongoing basis as there are changes in circumstances, facts, and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from these estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The COVID-19 pandemic and global macroeconomic conditions originating during the pandemic continue to directly and indirectly impact the Company’s business, results of operations and financial condition, including revenue, expenses, reserves and allowances. The Company continues to monitor developments that are highly uncertain, including supply chain disruptions and price increases, as well as the economic impact on domestic and international suppliers, customers, and markets. The Company assessed certain accounting matters that require consideration of forecasted financial information, including, but not limited to, its current expected credit losses, the carrying value of the Company's intangible assets and other long-lived assets, and valuation allowances in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of March 31, 2023 and through the date of this report. As a result of these assessments, there were no impairments or material increases in expected credit losses or valuation allowances that impacted the Company's condensed financial statements as of and for the three months ended March 31, 2023 and 2022. However, the Company's future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material impacts to the condensed financial statements in future reporting periods.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of the date of issuance of these unaudited condensed interim financial statements, the Company is not aware of any specific event or circumstance that would require the Company to update estimates, judgments or revise the carrying value of any assets or liabilities.</span></p>
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6623000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7941000
CY2023Q1 us-gaap Lease Income
LeaseIncome
1629000
CY2022Q1 us-gaap Lease Income
LeaseIncome
1399000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4660000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6040000
CY2023Q1 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
203000
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
200000
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1032000
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
768000
CY2023Q1 lnsr Accounts Receivables Payment Terms
AccountsReceivablesPaymentTerms
P30D
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
56000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-13000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
43000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
47000
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
16000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
34000
CY2023Q1 us-gaap Financing Receivable Change In Present Value Interest Income
FinancingReceivableChangeInPresentValueInterestIncome
12000
CY2022Q1 us-gaap Financing Receivable Change In Present Value Interest Income
FinancingReceivableChangeInPresentValueInterestIncome
6000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
13000
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
7000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
0
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
20000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
63000
CY2022Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
129000
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
11000
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
181000
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
332000
CY2023Q1 lnsr Contract With Customer Asset Recognised
ContractWithCustomerAssetRecognised
117000
CY2023Q1 us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
45000
CY2023Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
404000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
935000
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
823000
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
367000
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1391000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
970000
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
432000
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
361000
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1041000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
8974000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2947000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2639000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1865000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
883000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
640000
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5397000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4002000
CY2023Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
1912000
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
797000
CY2023Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
8359000
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
6941000
CY2023Q1 us-gaap Inventory Net
InventoryNet
15668000
CY2022Q4 us-gaap Inventory Net
InventoryNet
11740000
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
1629000
CY2022Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
1399000
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
18762000
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6917000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11845000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
18762000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6640000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
12122000
CY2023Q1 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P15Y
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
276000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
309000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3493000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4700000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
821000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1165000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1234000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1224000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1215000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1008000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
5178000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11845000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2096000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3348000
CY2023Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
431000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
437000
CY2023Q1 lnsr Accrued Customer Advances
AccruedCustomerAdvances
176000
CY2022Q4 lnsr Accrued Customer Advances
AccruedCustomerAdvances
171000
CY2023Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
85000
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
120000
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
705000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
624000
CY2023Q1 lnsr Additional Royalty Payments Percentage
AdditionalRoyaltyPaymentsPercentage
0.03
CY2023Q1 lnsr Employee Retention Credit Cares Act Retention Amount
EmployeeRetentionCreditCaresActRetentionAmount
1600000
CY2023Q1 lnsr Employee Retention Credit Cares Act Contingent Professional Fees
EmployeeRetentionCreditCaresActContingentProfessionalFees
250000
CY2023Q1 lnsr Employee Retention Credit Cares Act Retention Amount Recognized
EmployeeRetentionCreditCaresActRetentionAmountRecognized
0
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Common Stock Voting Rights
CommonStockVotingRights
The Company has a single class of common stock in which stockholders are entitled to one vote for each share of common stock
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
CY2021Q2 lnsr Maximum Value Of Common And Preferred Stock And Other Securities Issuable
MaximumValueOfCommonAndPreferredStockAndOtherSecuritiesIssuable
100000000.0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.73
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1209
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2891000
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M18D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.035
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.042
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.015
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.016
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.70
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.70
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1726000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1607000
CY2023Q1 lnsr Employee Service Share Based Compensation Non Vested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options Future Amortization Remainder Of Fiscal Year
EmployeeServiceShareBasedCompensationNonVestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptionsFutureAmortizationRemainderOfFiscalYear
3150000
CY2023Q1 lnsr Employee Service Share Based Compensation Non Vested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options Future Amortization Next Twelve Months
EmployeeServiceShareBasedCompensationNonVestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptionsFutureAmortizationNextTwelveMonths
1681000
CY2023Q1 lnsr Employee Service Share Based Compensation Non Vested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options Future Amortization Year Two
EmployeeServiceShareBasedCompensationNonVestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptionsFutureAmortizationYearTwo
873000
CY2023Q1 lnsr Employee Service Share Based Compensation Non Vested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options Future Amortization Year Three
EmployeeServiceShareBasedCompensationNonVestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptionsFutureAmortizationYearThree
159000
CY2023Q1 lnsr Employee Service Share Based Compensation Non Vested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options Future Amortization Year Four
EmployeeServiceShareBasedCompensationNonVestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptionsFutureAmortizationYearFour
5000
CY2023Q1 lnsr Employee Service Share Based Compensation Non Vested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options Future Amortization
EmployeeServiceShareBasedCompensationNonVestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptionsFutureAmortization
5868000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4272000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6674000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10716000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10716000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9967000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9967000
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.67
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.67
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2383000
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2125000

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0000950170-23-022253-index-headers.html Edgar Link pending
0000950170-23-022253-index.html Edgar Link pending
0000950170-23-022253.txt Edgar Link pending
0000950170-23-022253-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lnsr-20230331.htm Edgar Link pending
lnsr-20230331.xsd Edgar Link pending
lnsr-ex31_1.htm Edgar Link pending
lnsr-ex31_2.htm Edgar Link pending
lnsr-ex32_1.htm Edgar Link pending
lnsr-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
lnsr-20230331_cal.xml Edgar Link unprocessable
lnsr-20230331_def.xml Edgar Link unprocessable
lnsr-20230331_lab.xml Edgar Link unprocessable
lnsr-20230331_pre.xml Edgar Link unprocessable
lnsr-20230331_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending